Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic–pituitary–gonadal axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic–pituitary–gonadal axis

Published:2015-10 Issue: Volume:139 Page:166-174
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Kim Seon Mi,Yoo Taekyung,Lee So Young,Kim Eun Jeong,Lee Soo Min,Lee Min Hee,Han Min Young,Jung Seung-Hyun,Choi Jung-Hye,Ryu Keun Ho,Kim Hun-Taek

Funder

Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference40 articles.

1. Gonadotropin-releasing hormone and the control of gonadotrope function;Counis;Reprod. Nutr. Dev.,2005

2. The molecular basis of gonadotropin-releasing hormone (GnRH) action in the pituitary gonadotrope;Conn;Biol. Reprod.,1987

3. The use of gonadotrophin releasing-hormone analogues (GnRHa), in in-vitro fertilization: some clinical and experimental investigations of a direct effect on the human ovary;Pellicer;Hum. Reprod.,1992

4. The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers;Emons;Hum. Reprod.,1994

5. GnRH agonists and uterine leiomyomas;Broekmans;Hum. Reprod.,1996

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental and new investigational drugs for the treatment of uterine fibroids;Expert Opinion on Investigational Drugs;2024-04-17

2. Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids;Expert Opinion on Drug Metabolism & Toxicology;2022-08-03

3. Pharmacological characterization of linzagolix, a novel, orally active, non‐peptide antagonist of gonadotropin‐releasing hormone receptors;Clinical and Experimental Pharmacology and Physiology;2022-07-12

4. Highlights on Medical Treatment of Uterine Fibroids;Current Pharmaceutical Design;2021-10

5. First-in-Human, Double-Blind, Randomized Controlled Trial of an Oral Dose of GnRH Antagonist TU2670 in Healthy Women;The Journal of Clinical Endocrinology & Metabolism;2020-12-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3